Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
Nautilus Biotechnology to participate in investor conferences
09/06/2023 - 07:30 AM
SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences:
Morgan Stanley 21st Annual Global Healthcare Conference in New York, NY Management is scheduled to participate in a fireside chat on Wednesday, September 13th at 7:50 a.m. Pacific Time / 10:50 a.m. Eastern Time. Gilmartin Group Emerging Growth Company Showcase, Virtual Management is scheduled to present on Thursday, September 21st at 7:30 a.m. Pacific Time / 10:30 a.m. Eastern Time. Interested parties may access live and archived webcasts of the presentations on the “Investors” section of the company website at: www.nautilus.bio .
About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio .
Media Contact press@nautilus.bio
Investor Contact investorrelations@nautilus.bio
Nautilus Biotechnology Inc
NAUT Rankings
#2135 Ranked by Stock Gains
NAUT Stock Data
Industry
Analytical Laboratory Instrument Manufacturing
Sector
Manufacturing
About NAUT
born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. the extraordinary team at nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.